
Maruan Al-Shedivat
@alshedivat
ML @ Genesis Therapeutics | $200M Series B | We're hiring!
Before: @OpenAI, @GoogleAI (PhD fellow), @CarnegieMellon (PhD @mldcmu)
ID: 175133975
http://maruan.alshedivat.com 05-08-2010 18:39:44
637 Tweet
1,1K Takipçi
400 Takip Edilen

Super excited to preprint our work on developing a Biomolecular Emulator (BioEmu): Scalable emulation of protein equilibrium ensembles with generative deep learning from Microsoft Research AI for Science. #ML #AI #NeuralNetworks #Biology #AI4Science biorxiv.org/content/10.110…




Excited to finally share this work w/ Surya Ganguli. Tl;dr: we find the first closed-form analytical theory that replicates the outputs of the very simplest diffusion models, with median pixel wise r^2 values of 90%+. arxiv.org/abs/2412.20292






we've seen nothing yet! hosted a 9-13 yo vibe-coding event w. Robert Keus 👨🏼💻 this w-e (h/t Anton Osika – eu/acc Lovable Build) takeaway? AI is unleashing a generation of wildly creative builders beyond anything I'd have imagined and they grow up *knowing* they can build anything!

🧵(1/6) Delighted to share our ICML Conference 2025 spotlight paper: the Feynman-Kac Correctors (FKCs) in Diffusion Picture this: it’s inference time and we want to generate new samples from our diffusion model. But we don’t want to just copy the training data – we may want to sample

Join my team at Genesis Therapeutics ! 🧬 We're forging AI foundation models to unlock groundbreaking therapies for patients with severe diseases. We're hiring ML Scientists, Engineers, TPMs & Interns in foundation models, #LLMs , #RL, #diffusion models, and other cutting-edge areas of

Our Genesis Therapeutics ML team is headed to ICML Conference! I'll be there tomorrow. Maruan Al-Shedivat and David Li-Bland will be participating in the GenBio Workshop @ ICML25 to engage in timely discussions on the acceleration of AI for biological research and drug discovery. If you’re attending,



My longtime collaborator Dave Patterson (long-time faculty at UC Berkeley, Association for Computing Machinery Turing Award winner, and fellow Laude Institute board member) wrote a very good op-ed about how continued investing in basic science and technology research is essential for the U.S. Dave